Unlicensed & Shortage Drugs Supply

Quality Control at Karunesh Pharma

Unlicensed Medicines (ULMs) Supply

Karunesh BioSciences stands as a trusted leader in the unlicensed supply of pharmaceutical products, delivering life-saving solutions where conventional access falls short


  • Post-Trial Continuity: Patients often need continued access to treatment after clinical trials end, ensuring uninterrupted care until the therapy is approved, commercialized, and beyond - especially when the product remains globally unlicensed.
  • Cross-Border Access: Patients in other countries may urgently require the therapy and cannot wait for local marketing authorization to be granted - access is needed under national registration pathways.
  • Immediate Medical Need: Some patients rely on unlicensed medicines and cannot afford to delay treatment while waiting for local supply restoration - timely access is critical to their care.

With a patient-first mindset, global reach, and unwavering commitment to quality and compliance, Karunesh Biosciences continues to set the benchmark for excellence in unlicensed pharmaceutical supply.

Shortage Drugs Supply

A medicine shortage arises when a Marketing Authorization (MA) holder is unable to maintain a continuous supply of a medication within the country, impacting patients' access to essential treatments.


When hospitals encounter such shortages and no licensed alternatives are available locally, the only viable solution is often to source and import an unlicensed medicine from another country where the treatment is commercially available.


Understanding the critical impact of drug shortages on patient outcomes, Our Shortage Supply service is focused on closing critical sourcing gaps with precision in availability by sourcing and delivering essential medicines during local or global disruptions. Leveraging our global network, regulatory expertise, and efficient logistics, we ensure that healthcare providers have continued access to high-quality, compliant pharmaceuticals - even when standard supply chains fall short.

Quality Control at Karunesh Pharma